News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
228 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17781)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (176)
2 (7)
3 (6)
4 (219)
5 (189)
6 (212)
7 (230)
8 (95)
9 (2)
10 (7)
11 (143)
12 (249)
13 (209)
14 (213)
15 (105)
16 (3)
17 (5)
18 (200)
19 (228)
20 (201)
21 (239)
22 (96)
23 (3)
24 (6)
25 (203)
26 (268)
27 (220)
28 (279)
29 (127)
30 (2)
31 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2021 after the market close on Tuesday, November 9th, 2021.
October 19, 2021
·
1 min read
Genetown
Prime Medicine Announces Addition of Capabilities to Prime Editing Platform
Prime Medicine, Inc., a company founded to deliver on the promise of Prime Editing, announced the addition of capabilities to its platform based on recent scientific research.
October 19, 2021
·
2 min read
Drug Development
ONO PHARMA USA Announces Initiation of Phase 1 Study of ONO-4685, an Anti-PD-1/CD3 Bispecific Antibody, in Patients with Relapsed or Refractory T-cell Lymphoma in the U.S
ONO PHARMA USA , INC announced the initiation of a Phase 1 study of ONO-4685, an anti-PD-1/CD3 bispecific antibody, in patients with relapsed or refractory T-cell Lymphoma in the U.S.
October 19, 2021
·
2 min read
Business
Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement
Clovis Oncology, Inc. (NASDAQ: CLVS) and ITM Isotope Technologies Munich SE today announced the signing of a clinical supply agreement that provides Clovis Oncology with ITM’s therapeutic radioisotope no-carrier-added Lutetium-177
October 19, 2021
·
9 min read
Business
Agiliti Announces Third Quarter 2021 Earnings Release Date and Conference Call
Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its third quarter results after the market close on Tuesday, November 9, 2021, to be followed by a conference call at 5 p.m. Eastern Time on the same day.
October 19, 2021
·
1 min read
Genetown
Axcella, Now Axcella Therapeutics, to Host Virtual R&D Day on October 26, 2021
Axcella Therapeutics today announced that it will host a virtual R&D Day on Tuesday, October 26, 2021, at 10:00 a.m. ET.
October 19, 2021
·
6 min read
Biotech Bay
Better Therapeutics Enrolls First Patient in Real-World Evidence Study with Catalyst Health Network Evaluating BT-001, a Prescription Digital Therapeutic for Type 2 Diabetes
Better Therapeutics, Inc today announced the first patient has been enrolled in a real-world evidence study to evaluate the long-term effectiveness and healthcare utilization changes associated with the use of BT-001 for the treatment of type 2 diabetes.
October 19, 2021
·
12 min read
Biotech Bay
ReCode Therapeutics to Present Preclinical Data from mRNA-based Program for Cystic Fibrosis at Upcoming Virtual 2021 North American Cystic Fibrosis Conference
ReCode Therapeutics today announced that it will present preclinical data from its mRNA-based therapeutic program for cystic fibrosis (CF) in a poster presentation at the upcoming 2021 North American Cystic Fibrosis Conference (NACFC) to be held virtually from November 2-5, 2021.
October 19, 2021
·
1 min read
Genetown
Gamida Cell to Present at Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Gamida Cell to Present at Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting
October 19, 2021
·
4 min read
Business
Libra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer
Libra Therapeutics, Inc. today announced the appointment of Philip Lambert, Ph.D., as the company’s first chief scientific officer.
October 19, 2021
·
2 min read
Previous
10 of 23
Next